AlphaQuest LLC grew its position in Varex Imaging Co. (NASDAQ:VREX – Free Report) by 1,124.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 41,888 shares of the company’s stock after buying an additional 38,468 shares during the period. AlphaQuest LLC’s holdings in Varex Imaging were worth $611,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in VREX. Empowered Funds LLC grew its holdings in shares of Varex Imaging by 5.3% in the 3rd quarter. Empowered Funds LLC now owns 158,873 shares of the company’s stock valued at $1,894,000 after buying an additional 8,040 shares during the period. Quest Partners LLC acquired a new position in shares of Varex Imaging in the 3rd quarter valued at $41,000. LMR Partners LLP acquired a new position in shares of Varex Imaging in the 3rd quarter valued at $243,000. Factorial Partners LLC acquired a new position in shares of Varex Imaging in the 3rd quarter valued at $399,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Varex Imaging in the 3rd quarter valued at $312,000.
Varex Imaging Price Performance
Shares of NASDAQ VREX opened at $12.81 on Wednesday. The firm has a market cap of $527.77 million, a PE ratio of -10.95 and a beta of 0.56. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a 1-year low of $10.19 and a 1-year high of $18.30. The company has a fifty day moving average price of $13.50 and a 200 day moving average price of $13.40.
Analyst Ratings Changes
Several brokerages have recently issued reports on VREX. B. Riley reissued a “buy” rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th. StockNews.com raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Finally, Oppenheimer reduced their target price on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating for the company in a research note on Friday, February 7th.
Check Out Our Latest Report on Varex Imaging
Varex Imaging Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Articles
- Five stocks we like better than Varex Imaging
- What Are Earnings Reports?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is the MACD Indicator and How to Use it in Your Trading
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Which Wall Street Analysts are the Most Accurate?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREX – Free Report).
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.